Segalés Laura

Prof. Dr. Segalés Laura

Pompeu Fabra University, Barcelona, Catalonia, Spain
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
Rosa CasasRosa Casas
Rosa Casas
SCSara Castro-Barquero
Sara Castro-Barquero
FCFrancesca Crovetto
Francesca Crovetto
MLMarta Larroya
Marta Larroya
ARAna María Ruiz-León
Ana María Ruiz-León
Ramon EstruchRamon Estruch
Ramon Estruch
The information available on the effects of maternal dietary habits on systemic inflammation and adverse maternal outcomes is limited. We aimed to evaluate whether Dietary Inflammatory Index (DII) score during pregnancy is associated with maternal body mass index (BMI), Mediterranean diet (MD) adherence, and perinatal outcomes. At 19–23 weeks’ gestation, 1028 pregnant women were recruited. Dietary information was assessed using a 17-item dietary score to evaluate MD adherence and a validated 151-item food frequency questionnaire. DII score was established according to 33 food and nutritional proinflammatory and anti-inflammatory items. Participants were distributed into tertiles according to the DII score, where a lower DII score (first tertile) represented an anti-inflammatory diet and the third tertile represented the more proinflammatory diet. Maternal characteristics and perinatal outcomes were collected, and newborns’ birthweight percentiles were calculated. Adjusted logistic regression models were used to assess the association of the DII score with maternal and perinatal characteristics, setting the third tertile as the reference group. Women in the third tertile showed lower adherence to MD score compared to the first tertile: median (25th to 75th percentile) 9 (7 to 11) vs. 6 (4.25 to 8), p < 0.001. The proinflammatory diet was significantly associated with a higher maternal pre-pregnancy BMI (adjusted β = 0.88; 95% CI: 0.31 to 1.45) and lower newborn’s birthweight percentile (adjusted β = −9.84th; 95% CI: −19.6 to −0.12). These data show that a proinflammatory diet profile may be associated with maternal overweight and fetal undergrowth.

17 June 2019 in Virchows Archiv
Verified
Journal Article
Closed access
PDF file
RARaquel Albero-González
Raquel Albero-González
SHSilvia Hernández-Llodrà
Silvia Hernández-Llodrà
NJNuria Juanpere
Nuria Juanpere
MLMarta Lorenzo
Marta Lorenzo
ALAdrià Lloret
Adrià Lloret
JLJosep Lloreta-Trull
Josep Lloreta-Trull

26 May 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
SHSilvia Hernández-Llodrà
Silvia Hernández-Llodrà
NJNuria Juanpere
Nuria Juanpere
SMSilvia de Muga
Silvia de Muga
MLMarta Lorenzo
Marta Lorenzo
JGJoan Gil
Joan Gil
JTJosep Lloreta Trull
Josep Lloreta Trull
ERG overexpression plus SLC45A3 (prostein) and PTEN expression loss: Strong association of the triple hit phenotype with an aggressive pathway of prostate cancer progression ERG overexpression plus SLC45A3 (prostein) and PTEN expression loss: Strong association of the triple hit phenotype with an aggressive pathway of prostate cancer progression

17 September 2021 in The Prostate
Verified
Journal Article
Open access
PDF file
SHSilvia Hernández-Llodrà
Silvia Hernández-Llodrà
SLSegalés Laura
Segalés Laura
NJNuria Juanpere
Nuria Juanpere
TLTech Marta Lorenzo
Tech Marta Lorenzo
MSMarta Salido
Marta Salido
JLJosep Lloreta‐Trull
Josep Lloreta‐Trull
Background: In the non‐ETSfusion of prostate cancer (PCa) pathway,SPOPmutations emerge as a distinct oncogenic driver subclass. BothSPOPdownregulation and mutation can lead toSPOPtarget stabilization promoting dysregulation of key regulatory pathways.CHD1gene is commonly deleted in PCa.CHD1loss significantly co‐occurs withSPOPmutations, resulting in a PCa subclass with increased AR transcriptional activity and with a specific epigenetic pattern.Methods: In this study, SPOP alterations at mutational and protein levels andCHD1copy number alterations have been analyzed and correlated with ERG and PTEN protein expression and with the clinical pathological features of the patients.Results: SPOP protein loss has been detected in 42.9% of the cases, and it has been strongly associated with PTEN protein loss (p < .001).CHD1gene loss has been detected in 24.5% andSPOPmutations in 5.9% of the cases. Loss ofCHD1has been strongly associated withSPOPmutations (p = .003) and has shown a trend to be associated with ERGwtcancers (p = .08).The loss of SPOP protein (p = .01) and the combination of PTEN and SPOP protein loss (p = .002) were both statistically more common in grade group 5 cancers, with a prevalence of 60% and 37.5%, respectively. Furthermore, SPOP loss/PTEN loss and SPOPwt/PTEN loss phenotypes were strongly associated with extraprostatic perineural infiltration (p = .007). StrongCHD1loss was associated with a shorter time to PSA recurrence in the univariate (p = .04), and showed a trend to be associated with the PSA recurrence risk in the multivariate analysis (p = .058).Conclusions: The results of the present study suggest that the loss of SPOP protein expression, either alone or in combination with loss of PTEN and, on the other hand, a marked loss of theCHD1gene are very promising prognostic biomarkers in PCa.

15 May 2019 in The Prostate
Verified
Journal Article
Closed access
PDF file
SHSilvia Hernández-Llodrà
Silvia Hernández-Llodrà
SLSegalés Laura
Segalés Laura
ASAinara Safont
Ainara Safont
NJNuria Juanpere
Nuria Juanpere
MLMarta Lorenzo
Marta Lorenzo
JLJosep Lloreta‐Trull
Josep Lloreta‐Trull

3 January 2023 in Computer Methods and Programs in Biomedicine
Verified
Journal Article
Closed access
AUAndrea Urru
Andrea Urru
ANAyako Nakaki
Ayako Nakaki
OBOualid Benkarim
Oualid Benkarim
FCFrancesca Crovetto
Francesca Crovetto
SLSegalés Laura
Segalés Laura
MBMiguel Ángel González Ballester
Miguel Ángel González Ballester